Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice

Gut

Volumn 43, Issue 3, 1998, Pages 408-413

  Van Laethem, J L ^a,b   Eskinazi, R ^a   Louis, H ^a   Rickaert, F ^a   Robberecht, P ^b   Deviere J ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Adult respiratory distress syndrome; Interleukin 10; Pancreatitis; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; MOUSE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL;

EID: 0031693496     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.3.408     Document Type: Article

References (32)

1. Jungermann J, Lerch MM, Weidenbach H, et al. Dissassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulation. Am J Physiol 1995;G328-38.
2. Heath DL, Cruickshank DH, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Pancreas 1993;66:41-5.
3. Viedma JA, Perez-Mateo M, Dominguez JE, et al. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33: 1264-7.
4. Grewal HP, Mohey EDA, Gaber L, et al. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF alpha polyclonal antibody. Am J Surg 1994;167:214-19.
5. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1994;117:648-55.
6. Norman J, Franz M, Fink G, et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995;221:625-34.
7. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991;174:1549-55.
8. de Waal MR, Abrams J, Bennett B, et al. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
9. Gerard C, Bruyns C, Marchant A, et al. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177:547-50.
10. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin-10 prevents necrosis in murine experimental pancreatitis. Gastroenterology 1995;108:1917-22.
11. Rongione AJ, Kusske AM, Kwan K, et al. Interleukin-10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-7.
12. Norman J, Fink G, Franz M, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 1996;223:163-9.
13. Norman J, Fink G, Fray MS. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966-70.
14. 2 specific cytokine (IL-10) synthesis inhibitor factor by using a solid phase radioimmunoadsorbent assay. J Immunol 1990;145:2938-45.
15. Platteau B, Rits M, Cormant F, et al. Production and characterization of rat-rat hybridomas against DNP-Hamyten. In: Bazin H, ed. Rat hybridomas and rat monoclonal antibodies. Boca Raton, Florida: CRC Press, 1990:281-5.
16. Niederau C, Ferrell L, Grendell JH. Cerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript and secretin. Gastroenterology 1985;88: 1192-204.
17. Marchant A, Bruyns C, Vandenabeele P, et al. Interleukin-10 controls interferon γ and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994;24:1167-71.
18. Louis H, Le Moine O, Peny MO, et al. Production and role of interleukin-10 in concavalin A-induced hepatitis in mice. Hepatology 1997;25:1382-9.
19. Kusske AM, Rongione AJ, Ashley SW, et al. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996;120:284-9.
20. Norman J, Fink G, Messina J, et al. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996;120:515-21.
21. Gorelick FS, Adler G, Kern HF. Cerulein-induced pancreatitis. In: Go VLW, Di Magno EP, Gardner JD, et al, eds. The pancreas, biology, pathobiology and disease. 2nd edn. New York: Raven Press, 1993:501-26.
22. Le Moine O, Marchant A, Durand F, et al. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 1994;20:889-92.
23. Marchant A, Alegre ML, Hakim A, et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995;15:265-72.
24. Wan S, Marchant A, Desmet JM, et al. Human cytokine response to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996;111:469-77.
25. Van der Poll T, Marchant A, Buurmann W, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995;155:5397-401.
26. Louis H, Le Moine O, Peny MO, et al. Hepatoprotective role of interleukin-10 in galactosamine lipopolysaccharide mouse liver injury. Gastroenterology 1997;112:935-42.
27. Guice KS, Adham KT, Caty MG, et al. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989;210:740-7.
28. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b CD18-dependent mechanism. Am J Physiol 1991;261:G1051-6.
29. Entman ML, Yanker K, Shoji T, et al. Neutrophil-induced oxidative injury of cardiac myocytes: a compartmented system requiring CD11b/CD18 ICAM-1 adherence. J Clin Invest 1992;89:602-9.
30. Krakaver T. IL-10 inhibits the adhesion of leukocytic cells to IL-1 activated endothelials cells. Immunol Lett 1995;45:61-5.
31. Willems F, Marchant A, Delville JP, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecular-1 expression on human monocytes. Eur J Immunol 1994;24:1007-9.
32. Cassatalla MA, Meda L, Bouora S, et al. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysacchride. J Exp Med 1993;178:2207-11.